Tumor necrosis factor α is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1
暂无分享,去创建一个
[1] M. Cigolini,et al. Expression of plasminogen activator inhibitor-1 in human adipose tissue: a role for TNF-alpha? , 1999, Atherosclerosis.
[2] G. Hotamisligil,et al. The role of TNF alpha in adipocyte metabolism. , 1999, Seminars in cell & developmental biology.
[3] K. Uysal,et al. Functional analysis of tumor necrosis factor (TNF) receptors in TNF-alpha-mediated insulin resistance in genetic obesity. , 1998, Endocrinology.
[4] D. Loskutoff,et al. Tissue factor gene expression in the adipose tissues of obese mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[5] D. Loskutoff,et al. The adipocyte and hemostatic balance in obesity: studies of PAI-1. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[6] C. Fearns,et al. Role of tumor necrosis factor alpha in induction of murine CD14 gene expression by lipopolysaccharide , 1997, Infection and immunity.
[7] K. Uysal,et al. Protection from obesity-induced insulin resistance in mice lacking TNF-α function , 1997, Nature.
[8] Margaret S. Wu,et al. Targeted Disruption of the Tumor Necrosis Factor-α Gene: Metabolic Consequences in Obese and Nonobese Mice , 1997, Diabetes.
[9] M. Jensen,et al. Obesity and cardiovascular disease: is body structure a factor? , 1997, Current opinion in lipidology.
[10] M. Alessi,et al. PAI-1, Obesity, Insulin Resistance and Risk of Cardiovascular Events , 1997, Thrombosis and Haemostasis.
[11] Xing-li Wang,et al. Circulating transforming growth factor β1 and coronary artery disease , 1997 .
[12] P. Morange,et al. Production of Plasminogen Activator Inhibitor 1 by Human Adipose Tissue: Possible Link Between Visceral Fat Accumulation and Vascular Disease , 1997, Diabetes.
[13] P. Carmeliet,et al. Molecular genetics of the fibrinolytic and coagulation systems in haemostasis, thrombogenesis, restenosis and atherosclerosis. , 1997, Current opinion in lipidology.
[14] C. Fearns,et al. Induction of plasminogen activator inhibitor 1 gene expression in murine liver by lipopolysaccharide. Cellular localization and role of endogenous tumor necrosis factor-alpha. , 1997, The American journal of pathology.
[15] D. Loskutoff,et al. Elevated Expression of Transforming Growth Factor-β in Adipose Tissue from Obese Mice , 1997 .
[16] A. Prentice,et al. Obesity--the inevitable penalty of civilisation? , 1997, British medical bulletin.
[17] D. Loskutoff,et al. Tissue Distribution and Regulation of Plasminogen Activator Inhibitor-1 in Obese Mice , 1996, Molecular medicine.
[18] J. Harvey-Berino,et al. Amelioration of the inhibition of fibrinolysis in elderly, obese subjects by moderate energy intake restriction. , 1996, The American journal of clinical nutrition.
[19] S. Yamashita,et al. Enhanced expression of PAI–1 in visceral fat: Possible contributor to vascular disease in obeisty , 1996, Nature Medicine.
[20] D. Loskutoff,et al. Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide. , 1996, The Journal of clinical investigation.
[21] A. Pfeiffer,et al. Diabetic microvascular complications and growth factors. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[22] W. Fiers,et al. Two tumour necrosis factor receptors: structure and function. , 1995, Trends in cell biology.
[23] M. Lenardo,et al. Induction of apoptosis in mature T cells by tumour necrosis factor , 1995, Nature.
[24] R. Simsolo,et al. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. , 1995, The Journal of clinical investigation.
[25] B. Spiegelman,et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.
[26] B. Beutler,et al. How do tumor necrosis factor receptors work? , 1995, Journal of inflammation.
[27] J. McGill,et al. Factors Responsible for Impaired Fibrinolysis in Obese Subjects and NIDDM Patients , 1994, Diabetes.
[28] W. Border,et al. Transforming growth factor-beta and the pathogenesis of glomerular diseases. , 1994, Current opinion in nephrology and hypertension.
[29] B. Spiegelman,et al. Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance. , 1994, Endocrinology.
[30] R. Derynck,et al. Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[31] L. Tartaglia,et al. Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. , 1993, Journal of immunology.
[32] L. Tartaglia,et al. A novel domain within the 55 kd TNF receptor signals cell death , 1993, Cell.
[33] M. Blankenstein,et al. The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance. , 1993, Metabolism: clinical and experimental.
[34] H. Loetscher,et al. Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55 , 1993, The Journal of experimental medicine.
[35] Mike Rothe,et al. Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor , 1993, Cell.
[36] B. Spiegelman,et al. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.
[37] Y. Eguchi,et al. Cellular localization of type 1 plasminogen activator inhibitor messenger RNA and protein in murine renal tissue. , 1993, The American journal of pathology.
[38] L. Tartaglia,et al. Antiviral activity of tumor necrosis factor is signaled through the 55-kDa type I TNF receptor [corrected]. , 1992, Journal of Immunology.
[39] J. Primrose,et al. Reduction in Factor VII, Fibrinogen and Plasminogen Activator Inhibitor-1 Activity after Surgical Treatment of Morbid Obesity , 1992, Thrombosis and Haemostasis.
[40] W. Fiers,et al. Functional characterization of the human tumor necrosis factor receptor p75 in a transfected rat/mouse T cell hybridoma , 1992, The Journal of experimental medicine.
[41] L. Tartaglia,et al. Two TNF receptors. , 1992, Immunology today.
[42] P. Björntorp,et al. Abdominal fat distribution and disease: an overview of epidemiological data. , 1992, Annals of medicine.
[43] L. Tartaglia,et al. The two different receptors for tumor necrosis factor mediate distinct cellular responses. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[44] D. Loskutoff,et al. Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta. , 1991, The Journal of clinical investigation.
[45] P. Vague,et al. Fat distribution and plasminogen activator inhibitor activity in nondiabetic obese women. , 1989, Metabolism: clinical and experimental.
[46] C. Legnani,et al. Reduced fibrinolytic response in obese children: Association with high baseline activity of the fast acting plasminogen activator inhibitor (PAI-1) , 1988 .
[47] C. Kluft,et al. Plasminogen activator inhibitors. , 1987, Blood.
[48] D. Loskutoff,et al. Immunoradiometric assay to measure the binding of a specific inhibitor to tissue-type plasminogen activator. , 1985, The Journal of laboratory and clinical medicine.